New York: Researchers have found that whole-genome sequencing can be used to identify patients' risk for hereditary cancer which can potentially lead to improvements in cancer prevention, diagnosis and care.

The team from University of Texas' Southwestern Medical Centre used whole-genome sequencing to evaluate a series of 258 cancer patients' genomes to improve the ability to diagnose cancer-predisposing mutations.